SOPHiA GENETICS Stock (NASDAQ:SOPH)


ForecastOwnershipChartTranscripts

Previous Close

$5.40

52W Range

$2.59 - $5.70

50D Avg

$4.98

200D Avg

$4.60

Market Cap

$374.11M

Avg Vol (3M)

$104.81K

Beta

0.98

Div Yield

-

SOPH Company Profile


SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CH

Employees

423

IPO Date

Jul 23, 2021

Website

SOPH Performance


Latest Earnings Call Transcripts


Q1 26May 05, 26 | 12:00 AM
Q4 25Mar 03, 26 | 8:00 AM
Q3 25Nov 04, 25 | 8:00 AM

Peer Comparison


TickerCompany
SLPSimulations Plus, Inc.
NAKANakamoto Inc.
ACIUAC Immune S.A.
AGLAgilon Health, Inc.
OPRXOptimizeRx Corporation
NRCNational Research Corporation
ANROAlto Neuroscience, Inc.
LRMRLarimar Therapeutics, Inc.
DHDefinitive Healthcare Corp.
CLLSCellectis S.A.